NO180234C - Immunogent konjugat for behandling av septisk sjokk, forbindelser samt kovalent konjugat mellom D-glukosamin-disakkarid og et bærerprotein - Google Patents

Immunogent konjugat for behandling av septisk sjokk, forbindelser samt kovalent konjugat mellom D-glukosamin-disakkarid og et bærerprotein

Info

Publication number
NO180234C
NO180234C NO931655A NO931655A NO180234C NO 180234 C NO180234 C NO 180234C NO 931655 A NO931655 A NO 931655A NO 931655 A NO931655 A NO 931655A NO 180234 C NO180234 C NO 180234C
Authority
NO
Norway
Prior art keywords
conjugate
septic shock
compounds
treatment
carrier protein
Prior art date
Application number
NO931655A
Other languages
English (en)
Norwegian (no)
Other versions
NO931655D0 (no
NO180234B (no
NO931655L (no
Inventor
Massimo Porro
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO931655D0 publication Critical patent/NO931655D0/no
Publication of NO931655L publication Critical patent/NO931655L/no
Publication of NO180234B publication Critical patent/NO180234B/no
Publication of NO180234C publication Critical patent/NO180234C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
NO931655A 1992-05-07 1993-05-06 Immunogent konjugat for behandling av septisk sjokk, forbindelser samt kovalent konjugat mellom D-glukosamin-disakkarid og et bærerprotein NO180234C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87940392A 1992-05-07 1992-05-07

Publications (4)

Publication Number Publication Date
NO931655D0 NO931655D0 (no) 1993-05-06
NO931655L NO931655L (no) 1993-11-08
NO180234B NO180234B (no) 1996-12-02
NO180234C true NO180234C (no) 1997-03-12

Family

ID=25374087

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931655A NO180234C (no) 1992-05-07 1993-05-06 Immunogent konjugat for behandling av septisk sjokk, forbindelser samt kovalent konjugat mellom D-glukosamin-disakkarid og et bærerprotein

Country Status (14)

Country Link
EP (1) EP0570682B1 (de)
JP (1) JPH0641200A (de)
KR (1) KR930023369A (de)
AT (1) ATE155790T1 (de)
AU (1) AU664609B2 (de)
CA (1) CA2095588A1 (de)
DE (1) DE69312391T2 (de)
DK (1) DK0570682T3 (de)
ES (1) ES2104984T3 (de)
FI (1) FI932053A (de)
GR (1) GR3024706T3 (de)
IL (1) IL105605A0 (de)
NO (1) NO180234C (de)
SG (1) SG47582A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008214256A (ja) * 2007-03-02 2008-09-18 Yaizu Suisankagaku Industry Co Ltd 双頭型配糖化合物の製造方法及び双頭型配糖化合物並びに該双頭型配糖化合物を含有する糖鎖認識タンパク質結合剤
EP2326671A4 (de) * 2008-09-05 2012-10-03 Ca Nat Research Council Auf lps basierende impfstoffe
EP3436467A4 (de) * 2016-03-30 2020-03-18 Ayuvis Research, Inc. Neuartige zusammensetzungen und therapeutische verfahren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
EP0484403A4 (en) * 1989-07-27 1993-03-17 Univax Biologics Incorporated Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines

Also Published As

Publication number Publication date
NO931655D0 (no) 1993-05-06
SG47582A1 (en) 1998-04-17
EP0570682A1 (de) 1993-11-24
DE69312391D1 (de) 1997-08-28
DK0570682T3 (da) 1998-02-16
AU664609B2 (en) 1995-11-23
DE69312391T2 (de) 1997-12-11
JPH0641200A (ja) 1994-02-15
EP0570682B1 (de) 1997-07-23
FI932053A0 (fi) 1993-05-06
CA2095588A1 (en) 1993-11-08
AU3841993A (en) 1993-11-11
KR930023369A (ko) 1993-12-18
FI932053A (fi) 1993-11-08
ES2104984T3 (es) 1997-10-16
ATE155790T1 (de) 1997-08-15
NO180234B (no) 1996-12-02
NO931655L (no) 1993-11-08
GR3024706T3 (en) 1997-12-31
IL105605A0 (en) 1993-09-22

Similar Documents

Publication Publication Date Title
IL104696A0 (en) Dual carrier immunogenic construct and a vaccine containing the same
PL291855A1 (en) Method of obtaining covalent conjugate of oligosaccharide with proteinous support
AU3065489A (en) T-cell epitope as carriers molecule for conjugate vaccines
OA09776A (en) "Improved vaccine compositions".
NZ223009A (en) Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
CA2145397A1 (en) Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
NZ309713A (en) Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine
EP0220387A3 (en) Conjugate vaccines against infections by gramnegative bacteria, methods for their preparation and their use
HU9401511D0 (en) Vaccine against streptococcus suls infection
NO180234C (no) Immunogent konjugat for behandling av septisk sjokk, forbindelser samt kovalent konjugat mellom D-glukosamin-disakkarid og et bærerprotein
DK101196A (da) Histaminderivat, histamin-immunogen-konjugat samt antistof fremstillet mod konjugatet
AU6435596A (en) Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
ATE87926T1 (de) Ethylierte avermectine.
SE8703453D0 (sv) Preparation innehallande hogmolekylert bakteriellt protein, antikroppspreparation riktad deremot samt preparationernas anvendning
NZ337730A (en) use of an oligosaccharide hapten- carrier conjugate for immunizing against a bacterial or viral pathogen by administering
DK49685A (da) Fremgangsmaade til fremstilling af en modificeret levende pasteurella haemolytica vaccine
IT1248485B (it) Derivati della 1,4-benzotiazina ad azione immunostimolante e immonomodulatrice